Although inhibitors of endocannabinoid metabolism (FAAH inhibitors) have potential for clinical use, why are there no current clinical trials testing their effectiveness in humans? Question 34 options: A. cost-benefit analysis is not favorable B. federal law prohibits their development C. too difficult to generate enough soluble compound to study D. too risky due to neurological side effects and death resulting during a clinical trial
[Answered]: Although inhibitors of endocannabinoid metabolism…
Need help with your Neurological Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.